celiac disease

Healthy foods surrounding chalk drawing of gut
Biotech

Teva autoimmune antibody notches ph. 2 win in celiac disease

TEV ‘408 reduced the amount of intestinal damage caused by gluten significantly more than placebo, hitting the trial’s primary endpoint.
Darren Incorvaia Sep 2, 2026 10:52am
Takeda booth at AACR 2026

Takeda scraps another phase 2 celiac disease therapy

Jul 30, 2026 9:18am
A chessboard with blocks that read MA

Argenx acquires Forte for $2.2B for ph.2-stage vitiligo drug

Jul 27, 2026 6:08am
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Barinthus enters reverse merger with metabolic disease biotech

Sep 30, 2025 10:39am
Healthy foods surrounding chalk drawing of gut

Edited T cells allow gluten-sensitive mice to eat grains

Mar 20, 2025 7:16am
bowel

GI-focused CRO boosts trial tech with adaptive software

Feb 3, 2025 11:40am